Assignee
SIRIUS THERAPEUTICS INC
US·3 granted patents·7 pending applications·4 citations·filing 2017–2025
Top patents by PatentIndex Score
10 records- 0181US11981703B2Polynucleotide constructsSIRIUS THERAPEUTICS INC·Filed 2017·Granted May 14, 2024·2 cites·13 claims
- 0281US11597744B2Chiral phosphoramidite auxiliaries and methods of their useSIRIUS THERAPEUTICS INC·Filed 2018·Granted Mar 7, 2023·2 cites·20 claims
- 0374US2024247025A1Polynucleotide constructsSIRIUS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0473US12269839B2Chiral phosphoramidite auxiliaries and methods of their useSIRIUS THERAPEUTICS INC·Filed 2023·Granted Apr 8, 2025·0 cites·13 claims
- 0569US2024271143A1Polynucleic acid molecules targeting pcsk9 and uses thereofSIRIUS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0658US2025333738A1Polynucleic acid molecules for inhibiting expression of angptl3, pharmaceutical compositions, and uses thereofSIRIUS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0756US2025361508A1Polynucleic acid molecules targeting agt and uses thereofSIRIUS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0850US2025250573A1Polynucleic acid molecules for inhibiting expression of fxi, pharmaceutical compositions, and uses thereofSIRIUS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0948US2025188465A1Polynucleic acid molecules targeting apoc3 and uses thereofSIRIUS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1048US2025188464A1Polynucleic acid molecules for inhibiting expression of lp(a), pharmaceutical compositions, and uses thereofSIRIUS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SIRIUS THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →